These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16162458)

  • 1. Clinical and quality of life responses to high-dose chemotherapy plus autologous stem cell transplantation in patients with multiple sclerosis: two case reports.
    Novik AA; Ionova TI; Bisaga GN; Kishtovich AV; Fedorenko DA; Ivanov RA; Gorodokin GI
    Cytotherapy; 2005; 7(4):363-7. PubMed ID: 16162458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome.
    Kimiskidis V; Sakellari I; Tsimourtou V; Kapina V; Papagiannopoulos S; Kazis D; Vlaikidis N; Anagnostopoulos A; Fassas A
    Mult Scler; 2008 Mar; 14(2):278-83. PubMed ID: 17942513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
    Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
    Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosis.
    Xu J; Ji BX; Su L; Dong HQ; Sun XJ; Liu CY
    Chin Med J (Engl); 2006 Nov; 119(22):1851-5. PubMed ID: 17134581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis.
    Shevchenko YL; Novik AA; Kuznetsov AN; Afanasiev BV; Lisukov IA; Kozlov VA; Rykavicin OA; Ionova TI; Melnichenko VY; Fedorenko DA; Kulagin AD; Shamanski SV; Ivanov RA; Gorodokin G
    Exp Hematol; 2008 Aug; 36(8):922-8. PubMed ID: 18468768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stem cell transplantation in primary systemic vasculitis].
    Hensel M; Fiehn C; Ho AD
    Med Klin (Munich); 2003 Jan; 98(1):13-8. PubMed ID: 12540989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation.
    Fagius J; Lundgren J; Oberg G
    Mult Scler; 2009 Feb; 15(2):229-37. PubMed ID: 18805841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous stem cell transplantation with selected CD34+ cells and unmanipulated peripheral blood stem cells in patients with relapsed and refractory Hodgkin's lymphoma: a single centre experience.
    Ballova V; Ladicka M; Vranovsky A; Lakota J
    Neoplasma; 2008; 55(5):428-36. PubMed ID: 18665754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous hemopoietic stem cell transplantation for multiple sclerosis: is it worthwile?
    Fassas A; Mancardi GL
    Autoimmunity; 2008 Dec; 41(8):601-10. PubMed ID: 18958762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
    Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
    Crump M; Gluck S; Tu D; Stewart D; Levine M; Kirkbride P; Dancey J; O'Reilly S; Shore T; Couban S; Girouard C; Marlin S; Shepherd L; Pritchard KI
    J Clin Oncol; 2008 Jan; 26(1):37-43. PubMed ID: 18025439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives.
    Shevchenko JL; Kuznetsov AN; Ionova TI; Melnichenko VY; Fedorenko DA; Kurbatova KA; Gorodokin GI; Novik AA
    Ann Hematol; 2015 Jul; 94(7):1149-57. PubMed ID: 25711670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis.
    Shevchenko JL; Kuznetsov AN; Ionova TI; Melnichenko VY; Fedorenko DA; Kartashov AV; Kurbatova KA; Gorodokin GI; Novik AA
    Exp Hematol; 2012 Nov; 40(11):892-8. PubMed ID: 22771495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis.
    Capello E; Saccardi R; Murialdo A; Gualandi F; Pagliai F; Bacigalupo A; Marmont A; Uccelli A; Inglese M; Bruzzi P; Sormani MP; Cocco E; Meucci G; Massacesi L; Bertolotto A; Lugaresi A; Merelli E; Solari A; Filippi M; Mancardi GL;
    Neurol Sci; 2005 Dec; 26 Suppl 4():S200-3. PubMed ID: 16388358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consolidative involved field radiotherapy after high dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma: a case-control study.
    Oehler-Jänne C; Taverna C; Stanek N; Negretti L; Lütolf UM; Ciernik IF
    Hematol Oncol; 2008 Jun; 26(2):82-90. PubMed ID: 18085574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy with autologous stem cell transplantation for multiple myeloma: what predicts the outcome? Experience from a developing country.
    Kumar L; Ghosh J; Ganessan P; Gupta A; Hariprasad R; Kochupillai V
    Bone Marrow Transplant; 2009 Mar; 43(6):481-9. PubMed ID: 18978818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with high-dose immunosuppressive therapy followed by transplantation of autologous stem hematopoietic cells in patients with multiple sclerosis].
    Rossiev VA; Makarov SV; Aleksandrova IIa; Dolgikh GT; Lipshina SR; Stukalova TA; Trushina OA; Fedorova EIu; Lipina LN; Sivak VF; Korenev PP; Murashov BF
    Ter Arkh; 2002; 74(7):35-8. PubMed ID: 12181832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
    Klepin HD; Hurd DD
    Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of up-front treatment with a double stem cell transplantation in multiple myeloma.
    Eom KS; Min CK; Lee S; Kim YJ; Kim SY; Kim HJ; Lee JW; Min WS; Kim CC
    Jpn J Clin Oncol; 2006 Jul; 36(7):432-8. PubMed ID: 16782727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.